Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Beckman Coulter Inc.

www.beckmancoulter.com

Latest From Beckman Coulter Inc.

BD Sues Beckman Coulter Over Flow Cytometry Patents

Becton Dickinson claims Beckman Coulter has been knowingly violating several patents since at least 2015.

Intellectual Property Legal Issues

Abbott Adds IgM Test To COVID-19 Diagnostic Line-Up

The FDA has granted an emergency use authorization for a COVID-19 IgM antibody blood test that runs on Abbott’s Architect and Alinity platforms.

Coronavirus COVID-19 In Vitro Diagnostics

Beckman Coulter Addresses COVID-19 Testing From Multiple Angles

The company expects testing for IgM antibodies will be useful in areas where PCR testing is not keeping up with demand.

Coronavirus COVID-19 In Vitro Diagnostics

COVID-19 Registry Aims To Map And Address Potential Test Shortages

Medtech industry group AdvaMed has developed a registry to share data on how many COVID-19 diagnostic tests are available and where they are, with a goal of foreseeing and nipping in the bud potential test shortages. Thirteen diagnostic manufacturers – including Abbott, Roche, Siemens and Thermo Fisher Scientific – have partnered with AdvaMed on the initiative.

Commercial Policy
See All

Company Information

  • Industry
  • Research, Analytical Equipment & Supplies
  • Services
  • In Vitro Diagnostics
    • Chemistry, Immunoassay
    • Hematology, Coagulation
    • Molecular Diagnostics & Genetic Testing
UsernamePublicRestriction

Register